Marmar R. Moussa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marmar R. Moussa has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Aksenov
University of Connecticut
41 shared publications - Ali Lotfi
Department of Chemistry, University of Connecticut
41 shared publications - Anthony Athanasios Provatas
University of Connecticut Center for Environmental Science and Engineering, Storrs, USA
41 shared publications - Daniel W. Rosenberg
Centre for Molecular Oncology, Carole and Ray Neag Comprehensive Cancer Center, School of Medicine, University of Connecticut Health, Farmington, USA
41 shared publications - Haleh Vaziri
Department of Gastroenterology and Hepatology, University of Connecticut, Farmington, USA
41 shared publications - James J. Grady
Department of Public Health Sciences, UConn Health, Farmington, Connecticut, USA
41 shared publications
Latest Publications
- Open Access
Principal Genes: A PCA-based approach to highly variable genes selection for scRNA-Seq analysis
Single cell RNA-sequencing (scRNA-Seq) data are typically represented as cell-by-gene count matrices, which capture the expression of each gene as detected in the sampled cells; often a heterogeneous population of multiple different cell types or cell states. Almost all scRNA-Seq analysis workflows have a gene selection step prior to applying clustering algorithms which helps remove genes with low variability and hence reduce the high-dimensional gene space. A de-facto method for achieving selection of highly variable genes (HVG) uses dispersion and mean expression scores to evaluate the variability of each individual gene. However, methods based on direct mean-to-variance relationship for gene selection often suffer from susceptibility to variance instability and arbitrary determination of the optimal number of genes to use in downstream analysis tasks, additionally, they often prioritize genes with low abundance but high variance. Here, we propose an innovative method for selecting highly variable genes that is not based on mean to variance ratios: “Principal Genes (PG)” method; it utilizes the rotations (or loadings) from Principal Component Analysis (PCA) to calculate a novel variability score per gene that we name “Gene Principal Score (GPS)”. GPS helps evaluate the genes based on their contribution in the PCA rotations and hence ranks the genes according to their variability from highest to lowest variable genes. For efficient implementation we utilize Augmented Implicitly Restarted Lanczos Bidiagonalization methods to efficiently obtain Principal Components (PCs) associated with the largest variance. Genes with the highest GPS score, i.e. Principal Genes, can then be used for downstream analysis tasks, especially the clustering step. To test the performance of our highly variable gene identification method, we use several validation strategies, including clustering of labeled single cell RNA-Seq data (i.e. data with known ‘ground truth’ cell type labels). Furthermore, we measure the performance of our method against dispersion-based highly variable gene (HVG) selection approaches. We use several validation metrics, including sensitivity and adjusted rand index scores for clustering based on genes selected using our method against genes selected using HVG; and our validation datasets include six real labeled single cell RNA-Seq datasets. Our findings show that our new method, Principal Genes, is comparable and often favorable in performance in selecting highly variable genes and achieves ultra-fast gene selection from PCA results.
Open AccessPrincipal Genes: A PCA-based approach to highly variable genes selection for scRNA-Seq analysis
Single cell RNA-sequencing (scRNA-Seq) data are typically represented as cell-by-gene count matrices, which capture the expression of each gene as detected in the sampled cells; often a heterogeneous population of multiple different cell types or cell states. Almost all scRNA-Seq analysis workflows have a gene selection step prior to applying clustering algorithms which helps remove genes with low variability and hence reduce the high-dimensional gene space. A de-facto method for achieving selection of highly variable genes (HVG) uses dispersion and mean expression scores to evaluate the variability of each individual gene. However, methods based on direct mean-to-variance relationship for gene selection often suffer from susceptibility to variance instability and arbitrary determination of the optimal number of genes to use in downstream analysis tasks, additionally, they often prioritize genes with low abundance but high variance. Here, we propose an innovative method for selecting highly variable genes that is not based on mean to variance ratios: “Principal Genes (PG)” method; it utilizes the rotations (or loadings) from Principal Component Analysis (PCA) to calculate a novel variability score per gene that we name “Gene Principal Score (GPS)”. GPS helps evaluate the genes based on their contribution in the PCA rotations and hence ranks the genes according to their variability from highest to lowest variable genes. For efficient implementation we utilize Augmented Implicitly Restarted Lanczos Bidiagonalization methods to efficiently obtain Principal Components (PCs) associated with the largest variance. Genes with the highest GPS score, i.e. Principal Genes, can then be used for downstream analysis tasks, especially the clustering step. To test the performance of our highly variable gene identification method, we use several validation strategies, including clustering of labeled single cell RNA-Seq data (i.e. data with known ‘ground truth’ cell type labels). Furthermore, we measure the performance of our method against dispersion-based highly variable gene (HVG) selection approaches. We use several validation metrics, including sensitivity and adjusted rand index scores for clustering based on genes selected using our method against genes selected using HVG; and our validation datasets include six real labeled single cell RNA-Seq datasets. Our findings show that our new method, Principal Genes, is comparable and often favorable in performance in selecting highly variable genes and achieves ultra-fast gene selection from PCA results.
- Open Access
- 30 June 2026
- Published by Association for Computing Machinery (ACM)
- p. 1
ASI 2026 - Advances in Computational and Systems Immunology
- 30 June 2026
- Published by Association for Computing Machinery (ACM)
- p. 1
Open AccessASI 2026 - Advances in Computational and Systems Immunology
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S8: Baseline sociodemographic characteristics of 38 study participants based on urinary urolithin A production
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S8: Baseline sociodemographic characteristics of 38 study participants based on urinary urolithin A production
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Figure S2: Polyp tissues used for IMC analysis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Figure S2: Polyp tissues used for IMC analysis
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S3: List of serum markers analyzed in the patients
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S3: List of serum markers analyzed in the patients
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S6: Urinary urolithin metabolomic data after enzymatic hydrolysis, as described under Materials and methods
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S6: Urinary urolithin metabolomic data after enzymatic hydrolysis, as described under Materials and methods
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S9 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S9: Non-hydrolyzed fecal urolithin A levels
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S9 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S9: Non-hydrolyzed fecal urolithin A levels
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Figure S1: Selection of study participants
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Figure S1: Selection of study participants
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S10 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S10: Representativeness of Study Participants
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S10 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S10: Representativeness of Study Participants
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S1: List of food items study participants were asked to avoid during the 7-day washout period and 3-week walnut supplementation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A
Supplementary Table S1: List of food items study participants were asked to avoid during the 7-day washout period and 3-week walnut supplementation.